David A Conn

David A. Conn is an experienced executive in the diabetes care and medical device industries, currently serving as Executive Vice President at Glooko since November 2017, where the focus is on enhancing diabetes care through a global digital therapeutic platform. Previously, Conn held key leadership positions including President at Hygieia, Inc., and President at Facet Technologies LLC, contributing to advancements in insulin therapy and blood sampling devices. Conn also served as Chief Commercial Officer at AgaMatrix, where the company developed innovative blood glucose monitoring technologies. With a career spanning over three decades, Conn has held various roles in sales, marketing, and executive leadership across prominent companies including Johnson & Johnson LifeScan and Schering-Plough Healthcare Products. Conn holds a Bachelor of Science in Business Administration with a focus on Marketing and Management from Ashland University.